Regarding safety, cemiplimab’s adverse event (AE) profile was manageable and consistent with those established among PD-1 ...
At the molecular level, transcriptomic profiling of a single nucleus RNA-seq dataset of renal epithelial cells revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback